questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Phosphoprotéines
Phosphoprotéines : Questions médicales fréquentes
Diagnostic
5
Protéines
Analyse protéomique
Spectrométrie de masse
Immunoblotting
Imagerie par résonance magnétique
Protéines
Symptômes
5
Troubles métaboliques
Maladies neurodégénératives
Système immunitaire
Inflammation
Symptômes neurologiques
Maladies neurodégénératives
Douleur chronique
Protéines
Prévention
5
Exercice
Santé métabolique
Contrôles médicaux
Dépistage
Suppléments nutritionnels
Santé cellulaire
Traitements
5
Thérapies ciblées
Médicaments
Thérapie génique
Protéines
Essais cliniques
Inhibiteurs
Complications
5
Cancer
Maladies métaboliques
Maladies cardiovasculaires
Signalisation cellulaire
Troubles endocriniens
Hormones
Maladies auto-immunes
Protéines
Complications neurologiques
Troubles cognitifs
Facteurs de risque
5
Facteurs de risque
Prédispositions génétiques
Infections
Signalisation cellulaire
Obésité
Maladies métaboliques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Phosphoprotéines : Questions médicales les plus fréquentes",
"headline": "Phosphoprotéines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Phosphoprotéines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-18",
"dateModified": "2026-06-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Phosphoprotéines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines",
"url": "https://questionsmedicales.fr/mesh/D011506",
"about": {
"@type": "MedicalCondition",
"name": "Protéines",
"code": {
"@type": "MedicalCode",
"code": "D011506",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine Bad",
"alternateName": "bcl-Associated Death Protein",
"url": "https://questionsmedicales.fr/mesh/D051025",
"about": {
"@type": "MedicalCondition",
"name": "Protéine Bad",
"code": {
"@type": "MedicalCode",
"code": "D051025",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.049"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Caséines",
"alternateName": "Caseins",
"url": "https://questionsmedicales.fr/mesh/D002364",
"about": {
"@type": "MedicalCondition",
"name": "Caséines",
"code": {
"@type": "MedicalCode",
"code": "D002364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.150"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cavéoline-1",
"alternateName": "Caveolin 1",
"url": "https://questionsmedicales.fr/mesh/D051242",
"about": {
"@type": "MedicalCondition",
"name": "Cavéoline-1",
"code": {
"@type": "MedicalCode",
"code": "D051242",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.287"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cavéoline-2",
"alternateName": "Caveolin 2",
"url": "https://questionsmedicales.fr/mesh/D051243",
"about": {
"@type": "MedicalCondition",
"name": "Cavéoline-2",
"code": {
"@type": "MedicalCode",
"code": "D051243",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.356"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-kinase CDC2",
"alternateName": "CDC2 Protein Kinase",
"url": "https://questionsmedicales.fr/mesh/D016203",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-kinase CDC2",
"code": {
"@type": "MedicalCode",
"code": "D016203",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.360"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cortactine",
"alternateName": "Cortactin",
"url": "https://questionsmedicales.fr/mesh/D051356",
"about": {
"@type": "MedicalCondition",
"name": "Cortactine",
"code": {
"@type": "MedicalCode",
"code": "D051356",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.390"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine BCAR1",
"alternateName": "Crk-Associated Substrate Protein",
"url": "https://questionsmedicales.fr/mesh/D050719",
"about": {
"@type": "MedicalCondition",
"name": "Protéine BCAR1",
"code": {
"@type": "MedicalCode",
"code": "D050719",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.425"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phosphoprotéine DARPP-32 régulée par la dopamine et l'AMPc",
"alternateName": "Dopamine and cAMP-Regulated Phosphoprotein 32",
"url": "https://questionsmedicales.fr/mesh/D051937",
"about": {
"@type": "MedicalCondition",
"name": "Phosphoprotéine DARPP-32 régulée par la dopamine et l'AMPc",
"code": {
"@type": "MedicalCode",
"code": "D051937",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.459"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine du groupe de complémentation A de l'anémie de Fanconi",
"alternateName": "Fanconi Anemia Complementation Group A Protein",
"url": "https://questionsmedicales.fr/mesh/D052217",
"about": {
"@type": "MedicalCondition",
"name": "Protéine du groupe de complémentation A de l'anémie de Fanconi",
"code": {
"@type": "MedicalCode",
"code": "D052217",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.476"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine du groupe de complémentation D2 de l'anémie de Fanconi",
"alternateName": "Fanconi Anemia Complementation Group D2 Protein",
"url": "https://questionsmedicales.fr/mesh/D052236",
"about": {
"@type": "MedicalCondition",
"name": "Protéine du groupe de complémentation D2 de l'anémie de Fanconi",
"code": {
"@type": "MedicalCode",
"code": "D052236",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.484"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine du groupe de complémentation G de l'anémie de Fanconi",
"alternateName": "Fanconi Anemia Complementation Group G Protein",
"url": "https://questionsmedicales.fr/mesh/D052241",
"about": {
"@type": "MedicalCondition",
"name": "Protéine du groupe de complémentation G de l'anémie de Fanconi",
"code": {
"@type": "MedicalCode",
"code": "D052241",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.488"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Focal adhesion kinase 1",
"alternateName": "Focal Adhesion Kinase 1",
"url": "https://questionsmedicales.fr/mesh/D051417",
"about": {
"@type": "MedicalCondition",
"name": "Focal adhesion kinase 1",
"code": {
"@type": "MedicalCode",
"code": "D051417",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.493"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Paxilline",
"alternateName": "Paxillin",
"url": "https://questionsmedicales.fr/mesh/D051419",
"about": {
"@type": "MedicalCondition",
"name": "Paxilline",
"code": {
"@type": "MedicalCode",
"code": "D051419",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.665"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Phosvitine",
"alternateName": "Phosvitin",
"url": "https://questionsmedicales.fr/mesh/D010774",
"about": {
"@type": "MedicalCondition",
"name": "Phosvitine",
"code": {
"@type": "MedicalCode",
"code": "D010774",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Plectine",
"alternateName": "Plectin",
"url": "https://questionsmedicales.fr/mesh/D051190",
"about": {
"@type": "MedicalCondition",
"name": "Plectine",
"code": {
"@type": "MedicalCode",
"code": "D051190",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.736"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine p107 de type rétinoblastome",
"alternateName": "Retinoblastoma-Like Protein p107",
"url": "https://questionsmedicales.fr/mesh/D050720",
"about": {
"@type": "MedicalCondition",
"name": "Protéine p107 de type rétinoblastome",
"code": {
"@type": "MedicalCode",
"code": "D050720",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.747"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine p130 de type rétinoblastome",
"alternateName": "Retinoblastoma-Like Protein p130",
"url": "https://questionsmedicales.fr/mesh/D050717",
"about": {
"@type": "MedicalCondition",
"name": "Protéine p130 de type rétinoblastome",
"code": {
"@type": "MedicalCode",
"code": "D050717",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.755"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine du rétinoblastome",
"alternateName": "Retinoblastoma Protein",
"url": "https://questionsmedicales.fr/mesh/D016160",
"about": {
"@type": "MedicalCondition",
"name": "Protéine du rétinoblastome",
"code": {
"@type": "MedicalCode",
"code": "D016160",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.770"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Stathmine",
"alternateName": "Stathmin",
"url": "https://questionsmedicales.fr/mesh/D050777",
"about": {
"@type": "MedicalCondition",
"name": "Stathmine",
"code": {
"@type": "MedicalCode",
"code": "D050777",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.772"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Synapsine",
"alternateName": "Synapsins",
"url": "https://questionsmedicales.fr/mesh/D016704",
"about": {
"@type": "MedicalCondition",
"name": "Synapsine",
"code": {
"@type": "MedicalCode",
"code": "D016704",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.840"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine p53 suppresseur de tumeur",
"alternateName": "Tumor Suppressor Protein p53",
"url": "https://questionsmedicales.fr/mesh/D016159",
"about": {
"@type": "MedicalCondition",
"name": "Protéine p53 suppresseur de tumeur",
"code": {
"@type": "MedicalCode",
"code": "D016159",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.845"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Vitellogénines",
"alternateName": "Vitellogenins",
"url": "https://questionsmedicales.fr/mesh/D014819",
"about": {
"@type": "MedicalCondition",
"name": "Vitellogénines",
"code": {
"@type": "MedicalCode",
"code": "D014819",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.925"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Zyxine",
"alternateName": "Zyxin",
"url": "https://questionsmedicales.fr/mesh/D060589",
"about": {
"@type": "MedicalCondition",
"name": "Zyxine",
"code": {
"@type": "MedicalCode",
"code": "D060589",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.744.962"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Phosphoprotéines",
"alternateName": "Phosphoproteins",
"code": {
"@type": "MedicalCode",
"code": "D010750",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Martin Blackledge",
"url": "https://questionsmedicales.fr/author/Martin%20Blackledge",
"affiliation": {
"@type": "Organization",
"name": "Université Grenoble Alpes, Le Centre National de la Recherche Scientifique, Commissariatá l'Energie Atomique et aux Energies Alternatives, Institut de Biologie Structurale, Grenoble, France."
}
},
{
"@type": "Person",
"name": "Arminja N Kettenbach",
"url": "https://questionsmedicales.fr/author/Arminja%20N%20Kettenbach",
"affiliation": {
"@type": "Organization",
"name": "Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth College, Hanover, NH 03755, USA; Dartmouth Cancer Center, Lebanon, NH 03756, USA. Electronic address: Arminja.N.Kettenbach@dartmouth.edu."
}
},
{
"@type": "Person",
"name": "Gonzalo A Mardones",
"url": "https://questionsmedicales.fr/author/Gonzalo%20A%20Mardones",
"affiliation": {
"@type": "Organization",
"name": "Department of Physiology, School of Medicine, Universidad Austral de Chile, Valdivia, Chile."
}
},
{
"@type": "Person",
"name": "Hui Wu",
"url": "https://questionsmedicales.fr/author/Hui%20Wu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal University, Changsha, China."
}
},
{
"@type": "Person",
"name": "Hao Feng",
"url": "https://questionsmedicales.fr/author/Hao%20Feng",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal University, Changsha, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Structure of the Nipah virus polymerase phosphoprotein complex.",
"datePublished": "2024-10-07",
"url": "https://questionsmedicales.fr/article/39375338",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-024-52701-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "The role of phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) in regulating the progression of oral squamous cell carcinoma.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37852106",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.archoralbio.2023.105810"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Role of Vasodilator-stimulated Phosphoproteins in the Development of Malignant Tumors.",
"datePublished": "2023-11-14",
"url": "https://questionsmedicales.fr/article/37962042",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2174/0115680096262439231023110106"
}
},
{
"@type": "ScholarlyArticle",
"name": "Phosphoprotein dynamics of interacting T cells and tumor cells by HySic.",
"datePublished": "2023-12-26",
"url": "https://questionsmedicales.fr/article/38150364",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.celrep.2023.113598"
}
},
{
"@type": "ScholarlyArticle",
"name": "Increase of Phosphoprotein Expressions in Amotosalen/UVA-Treated Platelet Concentrates.",
"datePublished": "2024-02-09",
"url": "https://questionsmedicales.fr/article/38584699",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1159/000535060"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Phosphoprotéines",
"item": "https://questionsmedicales.fr/mesh/D010750"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Phosphoprotéines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Phosphoprotéines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-26",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Phosphoprotéines",
"description": "Comment détecte-t-on les phosphoprotéines ?\nQuels tests sont utilisés pour les phosphoprotéines ?\nLes phosphoprotéines sont-elles visibles sur des IRM ?\nPeut-on mesurer les niveaux de phosphoprotéines ?\nY a-t-il des biomarqueurs associés aux phosphoprotéines ?",
"url": "https://questionsmedicales.fr/mesh/D010750#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Phosphoprotéines",
"description": "Quels symptômes sont liés aux anomalies des phosphoprotéines ?\nLes phosphoprotéines affectent-elles le système immunitaire ?\nPeut-on observer des symptômes neurologiques ?\nLes phosphoprotéines sont-elles liées à des douleurs ?\nY a-t-il des symptômes spécifiques au cancer ?",
"url": "https://questionsmedicales.fr/mesh/D010750#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Phosphoprotéines",
"description": "Peut-on prévenir les déséquilibres de phosphoprotéines ?\nY a-t-il des habitudes à éviter ?\nL'exercice physique aide-t-il ?\nLes contrôles médicaux réguliers sont-ils importants ?\nLes suppléments nutritionnels sont-ils utiles ?",
"url": "https://questionsmedicales.fr/mesh/D010750#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Phosphoprotéines",
"description": "Comment traite-t-on les déséquilibres de phosphoprotéines ?\nY a-t-il des médicaments spécifiques pour les phosphoprotéines ?\nLes thérapies géniques peuvent-elles aider ?\nLes changements alimentaires influencent-ils les phosphoprotéines ?\nY a-t-il des traitements expérimentaux en cours ?",
"url": "https://questionsmedicales.fr/mesh/D010750#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Phosphoprotéines",
"description": "Quelles complications peuvent survenir avec des phosphoprotéines anormales ?\nLes phosphoprotéines sont-elles liées à des maladies cardiovasculaires ?\nPeut-on développer des troubles endocriniens ?\nY a-t-il des risques de maladies auto-immunes ?\nLes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D010750#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Phosphoprotéines",
"description": "Quels facteurs augmentent le risque de déséquilibres ?\nLe stress a-t-il un impact sur les phosphoprotéines ?\nL'âge influence-t-il les niveaux de phosphoprotéines ?\nLes infections peuvent-elles affecter les phosphoprotéines ?\nY a-t-il un lien avec l'obésité ?",
"url": "https://questionsmedicales.fr/mesh/D010750#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment détecte-t-on les phosphoprotéines ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les phosphoprotéines sont souvent détectées par des techniques comme la chromatographie et l'électrophorèse."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour les phosphoprotéines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests comme l'immunoblotting et la spectrométrie de masse sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les phosphoprotéines sont-elles visibles sur des IRM ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les IRM ne détectent pas directement les phosphoprotéines, mais peuvent montrer des effets indirects."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les niveaux de phosphoprotéines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des méthodes comme ELISA permettent de quantifier les phosphoprotéines dans des échantillons."
}
},
{
"@type": "Question",
"name": "Y a-t-il des biomarqueurs associés aux phosphoprotéines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines phosphoprotéines peuvent servir de biomarqueurs pour des maladies comme le cancer."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux anomalies des phosphoprotéines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anomalies peuvent entraîner des troubles métaboliques, des cancers ou des maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Les phosphoprotéines affectent-elles le système immunitaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines phosphoprotéines régulent la réponse immunitaire et peuvent influencer l'inflammation."
}
},
{
"@type": "Question",
"name": "Peut-on observer des symptômes neurologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des déséquilibres dans les phosphoprotéines peuvent contribuer à des symptômes neurologiques variés."
}
},
{
"@type": "Question",
"name": "Les phosphoprotéines sont-elles liées à des douleurs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des déséquilibres peuvent être associés à des douleurs chroniques dans certaines conditions."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques au cancer ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines phosphoprotéines sont impliquées dans la progression tumorale et peuvent provoquer des symptômes spécifiques."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les déséquilibres de phosphoprotéines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation saine et un mode de vie actif peuvent aider à maintenir l'équilibre des phosphoprotéines."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes à éviter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter le tabagisme et la consommation excessive d'alcool peut réduire les risques de déséquilibres."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la régulation des phosphoprotéines et la santé métabolique."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers peuvent aider à détecter précocement des anomalies liées aux phosphoprotéines."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels sont-ils utiles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments peuvent soutenir la santé cellulaire, mais il est important de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Comment traite-t-on les déséquilibres de phosphoprotéines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la condition sous-jacente et peut inclure des médicaments ou des thérapies ciblées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des médicaments spécifiques pour les phosphoprotéines ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments ciblent des voies de signalisation impliquant des phosphoprotéines dans le cancer."
}
},
{
"@type": "Question",
"name": "Les thérapies géniques peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les thérapies géniques peuvent corriger des anomalies dans les phosphoprotéines associées à des maladies."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires influencent-ils les phosphoprotéines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut influencer la régulation des phosphoprotéines et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux en cours ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des recherches sont en cours sur des inhibiteurs ciblant des phosphoprotéines dans diverses maladies."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des phosphoprotéines anormales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des phosphoprotéines anormales peuvent entraîner des cancers, des maladies métaboliques ou neurodégénératives."
}
},
{
"@type": "Question",
"name": "Les phosphoprotéines sont-elles liées à des maladies cardiovasculaires ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres peuvent contribuer à des maladies cardiovasculaires en affectant la signalisation cellulaire."
}
},
{
"@type": "Question",
"name": "Peut-on développer des troubles endocriniens ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les phosphoprotéines peuvent perturber la fonction endocrinienne et hormonale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies auto-immunes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines phosphoprotéines peuvent être impliquées dans le développement de maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres peuvent entraîner des complications neurologiques, y compris des troubles cognitifs."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de déséquilibres ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs comme l'alimentation, le mode de vie, et des prédispositions génétiques peuvent influencer les niveaux."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les phosphoprotéines ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la régulation des phosphoprotéines et la santé cellulaire."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il les niveaux de phosphoprotéines ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut modifier la régulation des phosphoprotéines et augmenter le risque de maladies."
}
},
{
"@type": "Question",
"name": "Les infections peuvent-elles affecter les phosphoprotéines ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections peuvent perturber la signalisation des phosphoprotéines et entraîner des déséquilibres."
}
},
{
"@type": "Question",
"name": "Y a-t-il un lien avec l'obésité ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité peut influencer les niveaux de phosphoprotéines et augmenter le risque de maladies métaboliques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 06/06/2026
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Université Grenoble Alpes, Le Centre National de la Recherche Scientifique, Commissariatá l'Energie Atomique et aux Energies Alternatives, Institut de Biologie Structurale, Grenoble, France.
Publications dans "Phosphoprotéines" :
3 publications dans cette catégorie
Affiliations :
Biochemistry and Cell Biology, Geisel School of Medicine at Dartmouth College, Hanover, NH 03755, USA; Dartmouth Cancer Center, Lebanon, NH 03756, USA. Electronic address: Arminja.N.Kettenbach@dartmouth.edu.
Publications dans "Phosphoprotéines" :
3 publications dans cette catégorie
Affiliations :
Department of Physiology, School of Medicine, Universidad Austral de Chile, Valdivia, Chile.
Center for Interdisciplinary Studies of the Nervous System (CISNe), Universidad Austral de Chile, Valdivia, Chile.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal University, Changsha, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Developmental Biology of Freshwater Fish, College of Life Science, Hunan Normal University, Changsha, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, Engineering Research Center of Green Development for Conventional Aquatic Biological Industry in the Yangtze River Economic Belt, Ministry of Education, College of Fisheries, Huazhong Agricultural University, Wuhan, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Agricultural Microbiology, Hubei Hongshan Laboratory, Engineering Research Center of Green Development for Conventional Aquatic Biological Industry in the Yangtze River Economic Belt, Ministry of Education, College of Fisheries, Huazhong Agricultural University, Wuhan, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing 100084, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing 100084, China. Electronic address: chen.yx@mail.tsinghua.edu.cn.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Physiology, School of Medicine, Universidad Austral de Chile, Valdivia, Chile.
Center for Interdisciplinary Studies of the Nervous System (CISNe), Universidad Austral de Chile, Valdivia, Chile.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Sciences, University of Calgary, 2500 University Dr. NW, Calgary, AB, T2N 1N4, Canada. moorhead@ucalgary.ca.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
Centre International de Recherche en Infectiologie, CIRI, INSERM, U1111, CNRS, UMR5308, Université Claude Bernard Lyon 1, ENS Lyon, Univ Lyon, Lyon, France.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, 430070, China.
Key Laboratory of Preventive Veterinary Medicine of Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, 430070, China.
Key Laboratory of Preventive Veterinary Medicine of Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, 430070, China.
Key Laboratory of Preventive Veterinary Medicine of Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, 430070, China.
Key Laboratory of Preventive Veterinary Medicine of Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, 430070, China.
Key Laboratory of Preventive Veterinary Medicine of Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, 430070, China.
Key Laboratory of Preventive Veterinary Medicine of Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, 430070, China.
Key Laboratory of Preventive Veterinary Medicine of Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
Publications dans "Phosphoprotéines" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, 430070, China.
Key Laboratory of Preventive Veterinary Medicine of Hubei Province, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, 430070, China.
Hubei Hongshan Laboratory, Wuhan, 430070, China.
Publications dans "Phosphoprotéines" :
The Nipah virus (NiV), a member of the Paramyxoviridae family, is notorious for its high fatality rate in humans. The RNA polymerase machinery of NiV, comprising the large protein L and the phosphopro...
The aim of this study was to explore the role of the tumor suppressor phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (PAG1) on oral squamous cell carcinoma (OSCC) and its mol...
Immunohistochemistry detected the expression of PAG1 in normal and tumor tissues. The PAG1 overexpressed OSCC cell lines were constructed by lentivirus transfection. Cell Counting Kit-8 assay (CCK-8),...
In contrast to the normal tissues, PAG1 expression was significantly downregulated in tumor tissues. Treatment with lentivirus transfection, the expression of PAG1 in the OSCC cell lines was increase....
Overexpression of PAG1 inhibited OSCC progression by activating autophagy, its mechanism might be related to inhibition of PI3K/Akt/mTOR signal pathway phosphorylation....
Vasodilator-stimulated phosphoprotein (VASP) is an actin-binding protein that includes three structural domains: Enabled/VASP homolog1 (EVH1), EVH2, and proline-rich (PRR). VASP plays an important rol...
Functional interactions between cytotoxic T cells and tumor cells are central to anti-cancer immunity. However, our understanding of the proteins involved is limited. Here, we present HySic (hybrid qu...
Pathogen inactivation treatment (PIT) has been shown to alter platelet function, phenotype, morphology and to induce a faster aging of platelet concentrates (PCs). Key pieces of information are still ...
This study investigated the impact of amotosalen/UVA on PCs, from a post-translational modifications (PTM) point of view. Phosphoproteomic analyses were conducted on resting platelets, right after the...
A two-arm study setting was carried out to compare PIT (amotosalen/UVA) to untreated PCs, on day 1 post-donation. Based on a pool-and-split approach, 12 PCs were split into two groups (treated and unt...
A total of 3,906 proteins and 7,334 phosphosites were identified, and 2,473 proteins and 2,214 phosphosites were observed in at least 5 to 6 replicates. Compared to untreated platelets, PIT platelets ...
This work provides a deep insight into the impact of amotosalen/UVA treatment from a phosphoprotein viewpoint on resting platelets. Clear changes in phosphorylation of proteins belonging to different ...
Reversible protein phosphorylation is a ubiquitous phenomenon essential for eukaryotic cellular processes. Recent advancements in research about neurodevelopmental disorders have prompted investigatio...
The coronavirus disease 2019 (COVID-19) pandemic is fading, however its etiologic agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues posing - despite the availability of lice...
Bronchopulmonary dysplasia (BPD) is a common chronic lung disorder characterized by impaired proximal airway and bronchoalveolar development in premature births. Secreted phosphoprotein 1 (SPP1) is in...
In several cancer types, metastasis is associated with poor prognosis, survival, and quality of life, representing a life risk more significant than the primary tumor itself. Metastasis is a multi-ste...
Secreted phosphoprotein 1 (SPP1), also known as osteopontin (OPN), is located on chromosome 4q22.1. This multifunctional secreted acidic glycoprotein is expressed intracellularly and extracellularly i...